ACTIVE

Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials

Export PDF
Incorporated on05/09/2024

Identity

Source · BCE/KBO

Oncodistinct Accelerating Oncology drug Development and Innovative strategies in Clinical Trials is a International non-profit organization incorporated in 2024. Its main activity is: Other human health activities. Its registered office is in Anderlecht.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 1013.225.475
Incorporation
05/09/2024
Legal form
International non-profit organization
Registered office
Rue Meylemeersch 90
1070 Anderlecht · BruxellesSee on map

Other companies at this address

Rue Meylemeersch 90 1070 Anderlecht
CompanyCBE no.
Association hospitalière de Bruxelles-Centre hospitalier Universitaire jules BORDET● Active
0257.981.101
Association Jules Bordet● Active
0408.695.444
ASSOCIATION PLURIDICIPLINAIRE DES MEDECINS DE L'INSTITUT JULES BORDET● Active
0441.433.340
Bordet'n Wellness● Active
0893.992.976
European Lung Cancer Working Party● Active
0438.167.608
FONDS ARIANE● Active
0432.729.866
LES AMIS DU NOUVEL INSTITUT BORDET● Active
0643.854.722
Société belge des Infirmiér(e)s en Oncologie● Active
0443.600.301

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other19/08/2026
    Changements à l'Organe d'administration
    PDF
  • Other09/09/2024
    CONSTITUTION
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 05/09/2024
    IncorporationInternational non-profit organization